Summary Hybrigenics SA (Hybrigenics) is a biopharmaceutical company that develops new targets and therapies against proliferative and non-cancerous diseases.Its lead product candidate Inecalcitol, is a vitamin D receptor agonist being assessed for various cancer indications including prostate cancer, chronic lymphocytic leukaemia and moderate to severe psoriasis.
The company is also investigating the action of deubiquitinating enzymes (DUB) in the recycling of onco-proteins and the utility of proprietary patented DUB inhibitors against various cancer indications.Hybrigenics’ employs its expertise in DUBs to discover and develop new treatments.
It also offers specialized scientific services for validating and inhibiting protein interactions in animal, plant or microbiological cells. Hybrigenics is headquartered in Paris, France.
Hybrigenics SA (ALHYG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Powered Air Purifying Respirator Market 2021-2025
The analyst has been monitoring the powered air purifying respirator market and it is poised to grow by $ 638.16 mn during 2021-2025 progressing at a CAGR of 6% during the forecast period. Our report on powered air purifying respirator market provides a holistic...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Microbial Identification Market 2020-2024
The analyst has been monitoring the microbial identification market and it is poised to grow by $ 991.90 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our report on microbial identification market provides a holistic analysis, market size and...
The Asia Pacific medical writing market is expected to reach US$ 983.51 million by 2027 from US$ 560.59 million in 2019; it is anticipated to grow at a CAGR of 7.3% during 2020–2027. The growth of Asia Pacific medical writing market is driven by increasing number of market players and growing government support in the healthcare sector....
300 pages •
By The Business Research Company
• Feb 2021
Major companies in the genito-urinary drugs market include Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc and Allergan Plc. The global genito-urinary drugs market is expected to grow from $49.24 billion in 2020 to $53.78 billion in 2021 at a compound annual growth rate (CAGR) of 9.2%. The growth is mainly due to the...
The Middle East and Africa medical cyclotron market is expected to reach US$ 6.69 million in 2027 from US$ 5.47 million in 2019, it is estimated to grow at a CAGR of 2.6% from 2020 to 2027. The growth of the Middle East and Africa medical cyclotron market is attributed to key driving factors such as increasing prevalence of cancer and growing...
The global level transmitter market size is expected to grow from USD 3.1 billion in 2020 to USD 3.5 billion by 2025, at a CAGR of 2.6%. The growth of the market is attributed to high focus on industrial automation and optimum utilization of resources, increased regulatory emphasis on industrial safety, growing demand for level transmitters...
Global Glycobiology Market, By Product (Enzymes, Instruments, Reagents and Kits), By Application (Drug Discovery, Disease Diagnostics, Virology, Cell Biology, Oncology, Others), By End User (Research Institutes, Diagnostic Centers, Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region, Competition,...
Global Sugar Market & Volume by Consumption, Production, Export, Import, Company Analysis & Forecast Sugarcane is a cash crop mostly grown in tropical countries and has a notable quality of serving as both Food and fuel sectors. Sugar is a sweet crystalline substance obtained from sugar cane as well...
The Quantum Computing market is expected to grow from USD 472 million in 2021 to USD 1,765 million by 2026, at a CAGR of 30.2%. The early adoption of quantum computing in the banking and finance sector is expected to fuel the growth of the market globally. Other key factors contributing to the growth of the quantum computing market include...
The global contract lifecycle management software market reached a value of US$ 1.51 Billion in 2020. Contract lifecycle management (CLM) software assists in efficiently managing the complete process of a contract signed between two or more organizations. It comprises of eight vital steps: contract drafting, negotiation, approval, compliance...
E-Commerce
Financial Services
Pharmaceutical
Healthcare
Automotive
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.